Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. [electronic resource]

By: Contributor(s): Producer: 20010531Description: 1605-11 p. digitalISSN:
  • 0149-5992
Subject(s): Online resources: In: Diabetes care vol. 23
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.